Bülent Karabulut

5PUBLICATIONS
72CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|May 27, 2026
Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study.

|Aug 30, 2022
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey.

Ahmet Özet, Faysal Dane, Nuri Faruk Aykan

|Apr 19, 2019
Evaluation of sarcopenia, sarcopenic obesity, and phase angle in geriatric gastrointestinal cancer patients: before and after chemotherapy

Derya Hopancı Bıçaklı, Rüksan Çehreli, Ahmet Özveren

|Oct 06, 2018
The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome.

Burcu Çakar, Zeki Sürmeli, Pınar Gürsoy Öner

Pageof 1

Frequent Collaborators

1 joint publications

Burcu Çakar

1 joint publications

Zeki Sürmeli

1 joint publications

Pınar Gürsoy Öner

1 joint publications

Elif Sıla Yelim